ENZ
vs
S&P 500
ENZ
S&P 500
Over the past 12 months, ENZ has underperformed S&P 500, delivering a return of +11% compared to the S&P 500's +18% growth.
Stocks Performance
ENZ vs S&P 500
Performance Gap
ENZ vs S&P 500
Performance By Year
ENZ vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Enzo Biochem Inc
Glance View
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. The company is headquartered in Farmingdale, New York and currently employs 451 full-time employees. The firm develops, manufactures and sells technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's segments include Enzo Clinical Lab, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Lab is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Life Sciences manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Enzo Therapeutics is a biopharmaceutical venture that developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.
